NAYA Biosciences Faces Delisting Notice
Ticker: IVF · Form: 8-K · Filed: Mar 31, 2025 · CIK: 1417926
Sentiment: bearish
Topics: delisting, compliance, regulatory-filing
TL;DR
NAYA Biosciences might get delisted, check their listing status ASAP.
AI Summary
NAYA Biosciences, Inc. filed an 8-K on March 25, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company, formerly known as INVO Bioscience, Inc., is incorporated in Nevada and has its principal executive offices in Sarasota, Florida.
Why It Matters
This filing indicates potential issues with NAYA Biosciences' continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading and overall viability.
Key Numbers
- 001-39701 — SEC File Number (Identifies the company's filing with the SEC.)
- 20-4036208 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- NAYA Biosciences, Inc. (company) — Registrant
- March 25, 2025 (date) — Date of earliest event reported
- INVO Bioscience, Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- Sarasota, Florida (location) — Address of principal executive offices
FAQ
What specific listing rule or standard has NAYA Biosciences failed to satisfy?
The filing does not specify the exact rule or standard that NAYA Biosciences has failed to satisfy, only that a notice has been issued.
What is the expected timeline for addressing the delisting concerns?
The filing does not provide a specific timeline for addressing the delisting concerns.
Has NAYA Biosciences taken any steps to rectify the situation leading to the delisting notice?
The filing does not detail any specific actions taken by NAYA Biosciences to rectify the situation.
What are the potential consequences if NAYA Biosciences cannot meet the continued listing requirements?
The primary consequence would be the delisting of the company's securities from the exchange, which could significantly impact liquidity and investor access.
When was NAYA Biosciences previously known as INVO Bioscience, Inc.?
The filing indicates the former company name was INVO Bioscience, Inc., but does not provide the exact date of the name change from that entity.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 31, 2025 regarding NAYA Biosciences, Inc. (IVF).